Mode
Text Size
Log in / Sign up
N/A N=87 Randomized Single-blind Treatment

Treatment of Older Veterans With Chronic Posttraumatic Stress Disorder

Combat Disorders · Post-traumatic Stress Disorder

Enrolled (actual)
87
Serious AEs
0.0%
Results posted
Aug 2015
Primary outcome: Primary: PTSD Checklist (PCL) — 57.46; 59.98; 47.00; 58.06 units on a scale

Study Design & Population

Study type
Interventional
Phase
N/A
Interventions
Prolonged Exposure Therapy (PE) (Behavioral); Relaxation Training (RT) (Behavioral)
Age
Adult, Older Adult · 60+ yrs
Sex
Male
Sponsor
US Department of Veterans Affairs
Primary completion
Mar 2013

Outcome Measures

OutcomeResultp-value
PRIMARY
PTSD Checklist (PCL)
57.46; 59.98; 47.00; 58.06; 58.37; 58.31
PRIMARY
Patient Health Questionnaire Depression Subscale (PHQ-9)
12.13; 15.12; 10.88; 14.80; 13.12; 13.92
PRIMARY
Clinician-Administered PTSD Scale Severity Score (CAPS)
66.02; 72.98; 48.48; 64.45; 29.16; 37.40
SECONDARY
Posttraumatic Cognitions Inventory (PTCI)
3.14; 3.78; 2.80; 3.72; 3.44; 3.84
SECONDARY
State-Trait Anxiety Inventory State Scale (STAI-S)
44.46; 41.67; 42.64; 43.75; 43.72; 42.63
SECONDARY
Sheehan Disability Scale (SDS)
18.15; 18.83; 15.31; 18.77; 21.06; 17.71
SECONDARY
Global Neuropsychological Deficits (Standardized, Composite)
.32; .42; .35; .40

Summary

This project represents the first randomized clinical trial of psychotherapy for older veterans with posttraumatic stress disorder (PTSD). It will compare relaxation training (RT) to prolonged exposure therapy (PE). The project will also examine whether cognitive impairment influences psychotherapy outcome. Primary hypotheses: (1) Subjects in the PE condition will have significantly less severe PTSD symptoms, depressive symptoms, and functional impairment than subjects in the RT condition at posttest; (2) Executive functioning will modify the response to both treatments, such that those with impaired executive functioning will demonstrate a smaller reduction in PTSD symptoms (representing less clinically significant change).

Eligibility Criteria

Inclusion Criteria

  • Veterans with primary diagnosis of chronic PTSD due to combat or non-sexual military trauma; comorbid mood and anxiety disorders are expected, and will be permitted (to maximize generalizability) if PTSD symptoms are judged to be predominant based on primacy and severity of symptoms
  • Male
  • Age 60 or older; and
  • English literacy.

Exclusion Criteria

  • Unmanaged psychosis or manic episodes in past year
  • Substance dependence or alcohol dependence in past 3 months
  • Concurrent psychotherapies targeting PTSD or exposure therapy for other anxiety symptoms [veterans who are engaged in treatment for non-PTSD symptoms (e.g., 12-step programs for substance problems) will be eligible]
  • Severe cardiovascular or respiratory disease that would make it difficult to ensure regular attendance at psychotherapy sessions
  • Probable dementia (based on chart diagnosis); or
  • Head trauma resulting in loss of consciousness longer than 20 minutes.
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT00539279). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search